Drug Profile
OMP 131R10 companion diagnostic
Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Guardant Health; OncoMed Pharmaceuticals
- Class Diagnostic agents
- Mechanism of Action RSPO3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer